Mass measles vaccination in urban Burkina Faso, 1998.
OBJECTIVE
To assess the impact of the National Immunization Days (NIDs) on measles vaccine coverage in Burkina Faso in 1998.


METHODS
During the week after the campaign, in which measles vaccine was offered to children aged 9-59 months in six cities regardless of vaccination history, a cluster survey was conducted in Ouagadougou and Bobo Dioulasso, the country's two largest cities. Interviewers visited the parents of 1267 children aged up to 59 months and examined vaccination cards. We analysed the data using cluster sample methodology for the 1041 children who were aged 9-59 months.


RESULTS
A total of 604 (57%) children had received routine measles vaccination prior to the campaign, and 823 (79%) were vaccinated during the NIDs. Among those who had previously had a routine vaccination, 484 (81%) were revaccinated during the NIDs. Among those not previously vaccinated, 339 (78%) received one dose during the NIDs. After the campaign, 943 (91%) children had received at least one dose of measles vaccine. Better socioeconomic status was associated with a higher chance of having been vaccinated routinely, but it was not associated with NID coverage.


CONCLUSIONS
The mass campaign enabled a substantial increase in measles vaccine coverage to be made because it reached a high proportion of children who were difficult to reach through routine methods.
Zuber
P L
PL
Centers for Disease Control and Prevention, 1600 Clifton Road MS-E05, Atlanta, GA 30333, USA. pzuber@cdc.gov
Conombo
K S
KS
Traoré
A D
AD
Millogo
J D
JD
Ouattara
A
A
Ouédraogo
I B
IB
Valian
A
A
D002050:Burkina Faso / Q000453:epidemiology; D017028:Caregivers; D002675:Child, Preschool; D016000:Cluster Analysis; D003625:Data Collection; D004522:Educational Status; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D007223:Infant; D008297:Male; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage*; D014505:Urban Population
D008458:Measles Vaccine